Department of Sport, Food and Natural Sciences, Faculty of Education, Arts and Sports, Western Norway University of Applied Sciences, Sogndal, Norway.
Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway.
Br J Sports Med. 2019 Jul;53(14):879-885. doi: 10.1136/bjsports-2018-099778. Epub 2019 May 31.
We aimed to examine the relationship between cycling (particularly commuter cycling) and risk factors associated with cardiovascular diseases (CVDs) including body composition, blood lipids and cardiorespiratory fitness. This study differed from our recent (Part 1) systematic review in that risk factors for CVD were analysed as continuous variables rather than being present or absent.
Systematic review and meta-analysis.
We searched four databases (Web of Science, MEDLINE, SPORTDiscus and Scopus). All quantitative studies, published until August 2017, were included when a general population was investigated, cycling was assessed either in total or as a transportation mode, and CVD risk factors were reported.
We analysed body composition, physical activity (PA), cardiorespiratory fitness (CRF), blood lipids and blood pressure (BP). Skinfold, waist circumference and body mass index were analysed and prioritised in that order when more than one measure were available. PA included measures of counts per minutes, moderate-to-vigorous PA or minutes per week. CRF included results of maximal tests with or without expired air or submaximal test. For blood lipids and BP, separate analyses were run for low-density and high-density lipoprotein, triglycerides, total cholesterol, systolic BP and diastolic BP. Studies were excluded when reporting dichotomous outcomes or when cycling and walking were combined. Heterogeneity was investigated using I.
Fifteen studies were included; the majority reported commuter cycling. In total, we included 5775 cyclists and 39 273 non-cyclists. Cyclists had more favourable risk factor levels in body composition -0.08 (95% CI -0.13 to -0.04), PA 0.13 (95% CI 0.06 to 0.20), CRF 0.28 (95% CI 0.22 to 0.35) and blood lipids compared with non-cyclists. There was no sex difference in risk reduction.
CONCLUSION/IMPLICATION: Cycling mitigated the risk factor profile for CVD. A strength of this systematic review is that all the risk factors were analysed as continuous variables. These data provide evidence for practitioners, stakeholders, policy-makers and city planners to accommodate and promote cycling.
PROSPERO CRD42016052421.
本研究旨在探讨与心血管疾病(CVD)相关的风险因素(包括身体成分、血脂和心肺功能)与骑自行车(尤其是通勤骑行)之间的关系。与我们最近的(第 1 部分)系统综述不同,本研究将 CVD 风险因素分析为连续变量,而不是存在或不存在。
系统综述和荟萃分析。
我们在四个数据库(Web of Science、MEDLINE、SPORTDiscus 和 Scopus)中进行了检索。当研究对象为一般人群、评估的是自行车总骑行量或作为交通方式的骑行、且报告了 CVD 风险因素时,纳入所有发表至 2017 年 8 月的定量研究。
我们分析了身体成分、身体活动(PA)、心肺功能(CRF)、血脂和血压(BP)。当有多种测量方法时,优先分析皮褶厚度、腰围和体重指数。PA 包括每分钟计数、中高强度 PA 或每周分钟数的测量。CRF 包括有或没有呼气末气体的最大测试结果或亚最大测试。对于血脂和 BP,单独分析了低密度脂蛋白和高密度脂蛋白、甘油三酯、总胆固醇、收缩压和舒张压。当报告二分结果或当自行车骑行和步行合并时,将研究排除在外。使用 I2 来调查异质性。
纳入了 15 项研究;其中大多数报告了通勤骑行。总共纳入了 5775 名自行车骑行者和 39273 名非自行车骑行者。与非自行车骑行者相比,自行车骑行者的身体成分风险因素水平更低(-0.08,95%CI -0.13 至 -0.04)、PA 更高(0.13,95%CI 0.06 至 0.20)、CRF 更好(0.28,95%CI 0.22 至 0.35)和血脂水平更好。在降低风险方面,没有性别差异。
结论/意义:骑自行车可以减轻 CVD 的风险因素。本系统综述的一个优势在于,所有风险因素都被分析为连续变量。这些数据为从业者、利益相关者、政策制定者和城市规划者提供了证据,以容纳和促进自行车骑行。
PROSPERO CRD42016052421。